These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23755848)

  • 1. Pyridone-conjugated monobactam antibiotics with gram-negative activity.
    Brown MF; Mitton-Fry MJ; Arcari JT; Barham R; Casavant J; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Lall MS; Lemmon MM; Li C; Lin J; McCurdy SP; McElroy E; McPherson C; Marr ES; Mueller JP; Mullins L; Nikitenko AA; Noe MC; Penzien J; Plummer MS; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Tomaras A; Young JA; Zaniewski RP
    J Med Chem; 2013 Jul; 56(13):5541-52. PubMed ID: 23755848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of C(4) substituted monobactams as antibacterial agents against multidrug-resistant Gram-negative bacteria.
    Kou Q; Wang T; Zou F; Zhang S; Chen Q; Yang Y
    Eur J Med Chem; 2018 May; 151():98-109. PubMed ID: 29605810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Pyridone-Conjugated Monosulfactams as Potent and Broad-Spectrum Antibiotics for Multidrug-Resistant Gram-Negative Infections.
    Tan L; Tao Y; Wang T; Zou F; Zhang S; Kou Q; Niu A; Chen Q; Chu W; Chen X; Wang H; Yang Y
    J Med Chem; 2017 Apr; 60(7):2669-2684. PubMed ID: 28287720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria.
    Fu HG; Hu XX; Li CR; Li YH; Wang YX; Jiang JD; Bi CW; Tang S; You XF; Song DQ
    Eur J Med Chem; 2016 Mar; 110():151-63. PubMed ID: 26827160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections.
    Montgomery JI; Brown MF; Reilly U; Price LM; Abramite JA; Arcari J; Barham R; Che Y; Chen JM; Chung SW; Collantes EM; Desbonnet C; Doroski M; Doty J; Engtrakul JJ; Harris TM; Huband M; Knafels JD; Leach KL; Liu S; Marfat A; McAllister L; McElroy E; Menard CA; Mitton-Fry M; Mullins L; Noe MC; O'Donnell J; Oliver R; Penzien J; Plummer M; Shanmugasundaram V; Thoma C; Tomaras AP; Uccello DP; Vaz A; Wishka DG
    J Med Chem; 2012 Feb; 55(4):1662-70. PubMed ID: 22257165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial evaluation against resistant Gram-negative bacteria of monobactams bearing various substituents on oxime residue.
    Li ZW; Lu X; Wang YX; Hu XX; Fu HG; Gao LM; You XF; Tang S; Song DQ
    Bioorg Chem; 2020 Jan; 94():103487. PubMed ID: 31831161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of efficacious Pseudomonas aeruginosa-targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic model.
    Murphy-Benenato KE; Bhagunde PR; Chen A; Davis HE; Durand-Réville TF; Ehmann DE; Galullo V; Harris JJ; Hatoum-Mokdad H; Jahić H; Kim A; Manjunatha MR; Manyak EL; Mueller J; Patey S; Quiroga O; Rooney M; Sha L; Shapiro AB; Sylvester M; Tan B; Tsai AS; Uria-Nickelsen M; Wu Y; Zambrowski M; Zhao SX
    J Med Chem; 2015 Mar; 58(5):2195-205. PubMed ID: 25658376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation-based resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosa.
    Tomaras AP; Crandon JL; McPherson CJ; Banevicius MA; Finegan SM; Irvine RL; Brown MF; O'Donnell JP; Nicolau DP
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4197-207. PubMed ID: 23774440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial evaluation of new monobactams.
    Thu ZM; Sun J; Ji J; He L; Ji J; Iqbal Z; Myo KK; Gao Y; Zhai L; Mu Y; Tang D; Vidari G; Yang H; Yang Z
    Bioorg Med Chem Lett; 2021 May; 39():127878. PubMed ID: 33636305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and Function of the PiuA and PirA Siderophore-Drug Receptors from Pseudomonas aeruginosa and Acinetobacter baumannii.
    Moynié L; Luscher A; Rolo D; Pletzer D; Tortajada A; Weingart H; Braun Y; Page MG; Naismith JH; Köhler T
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agents.
    McAllister LA; Montgomery JI; Abramite JA; Reilly U; Brown MF; Chen JM; Barham RA; Che Y; Chung SW; Menard CA; Mitton-Fry M; Mullins LM; Noe MC; O'Donnell JP; Oliver RM; Penzien JB; Plummer M; Price LM; Shanmugasundaram V; Tomaras AP; Uccello DP
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6832-8. PubMed ID: 23046961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of pyrazole encompassing 2-pyridone derivatives as antibacterial agents.
    Desai NC; Rajpara KM; Joshi VV
    Bioorg Med Chem Lett; 2013 May; 23(9):2714-7. PubMed ID: 23511017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial action of a heat-stable form of L-amino acid oxidase isolated from king cobra (Ophiophagus hannah) venom.
    Lee ML; Tan NH; Fung SY; Sekaran SD
    Comp Biochem Physiol C Toxicol Pharmacol; 2011 Mar; 153(2):237-42. PubMed ID: 21059402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of antibacterial activity of the MB-1 siderophore-monobactam conjugate using an efflux pump inhibitor.
    Tomaras AP; Crandon JL; McPherson CJ; Nicolau DP
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2439-42. PubMed ID: 25605364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and antibiotic activity of monobactam analogues of nocardicins.
    Gerardin-Charbonnier C; Auberger S; Molina L; Achilefu S; Manresa MA; Vinardell P; Infante MR; Selve C
    Prep Biochem Biotechnol; 1999 Aug; 29(3):257-72. PubMed ID: 10431930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activity of C-4 thio- and dithiocarbamate monobactam derivatives.
    Cascio G; Lorenzi L; Caglio D; Manghisi E; Arcamone F; Guanti G; Satta G; Morandotti G; Sperning R
    Farmaco; 1996 Mar; 51(3):189-96. PubMed ID: 8688141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections.
    Mitton-Fry MJ; Arcari JT; Brown MF; Casavant JM; Finegan SM; Flanagan ME; Gao H; George DM; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Irvine R; Lall MS; Megan Lemmon M; Li C; Lin J; McCurdy SP; Mueller JP; Mullins L; Niosi M; Noe MC; Pattavina D; Penzien J; Plummer MS; Risley H; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Winton J; Young JA
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5989-94. PubMed ID: 22892121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.
    Mitscher LA
    Chem Rev; 2005 Feb; 105(2):559-92. PubMed ID: 15700957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.